It's important to note that the trial balance differs from the balance sheet. This is an internal report that stays in the accounting department. The balance sheet, on the other hand ...

ORMP intends to launch a Phase 3 oral insulin trial in the U.S. under a differentiated ... At the same time, ORMP is also leveraging its balance sheet – about $142 million in cash, equivalents ...